Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel S Peeper

Showing results (31-40 of 117) with videos related to

Pageof 12
Sort By:
Carcinogenesis|September 11, 2015
Autophagy-mediated degradation of nuclear envelope proteins during oncogene-induced senescenceChristelle Lenain, Olga Gusyatiner, Sirith Douma, et al.
Molecular and Cellular Biology|May 6, 2009
A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasisMarjon A Smit, Thomas R Geiger, Ji-Ying Song, et al.
Cancer Immunology, Immunotherapy : CII|February 12, 2021
Metabolic profiles of regulatory T cells in the tumour microenvironmentDisha Rao, Fabienne Verburg, Kathrin Renner, et al.
Carcinogenesis|November 28, 2009
Functional identification of LRF as an oncogene that bypasses RASV12-induced senescence via upregulation of CYCLIN ELiesbeth C W Vredeveld, Benjamin D Rowland, Sirith Douma, et al.
Nature|August 27, 2004
Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkBSirith Douma, Theo Van Laar, John Zevenhoven, et al.
Cell Death Discovery|November 28, 2025
Inhibition of TBK1/IKKε mediated RIPK1 phosphorylation sensitizes tumors to immune cell killingAnastasia Piskopou, David W Vredevoogd, Xiangjun Kong, et al.
Cancer Cell|August 2, 2002
E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrestBenjamin D Rowland, Serguei G Denissov, Sirith Douma, et al.
The EMBO Journal|January 30, 2023
TSC2 regulates tumor susceptibility to TRAIL-mediated T-cell killing by orchestrating mTOR signalingChun-Pu Lin, Joleen J H Traets, David W Vredevoogd, et al.
Oncotarget|July 5, 2016
Integrated in vivo genetic and pharmacologic screening identifies co-inhibition of EGRF and ROCK as a potential treatment regimen for triple-negative breast cancerSedef Iskit, Cor Lieftink, Pasi Halonen, et al.
Nature Cell Biology|January 29, 2002
A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescenceDaniel S Peeper, Avi Shvarts, Thijn Brummelkamp, et al.
Pageof 12

Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
Carcinogenesis|September 11, 2015
Autophagy-mediated degradation of nuclear envelope proteins during oncogene-induced senescenceChristelle Lenain, Olga Gusyatiner, Sirith Douma, et al.
Molecular and Cellular Biology|May 6, 2009
A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasisMarjon A Smit, Thomas R Geiger, Ji-Ying Song, et al.
Cancer Immunology, Immunotherapy : CII|February 12, 2021
Metabolic profiles of regulatory T cells in the tumour microenvironmentDisha Rao, Fabienne Verburg, Kathrin Renner, et al.
Carcinogenesis|November 28, 2009
Functional identification of LRF as an oncogene that bypasses RASV12-induced senescence via upregulation of CYCLIN ELiesbeth C W Vredeveld, Benjamin D Rowland, Sirith Douma, et al.
Nature|August 27, 2004
Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkBSirith Douma, Theo Van Laar, John Zevenhoven, et al.
Cell Death Discovery|November 28, 2025
Inhibition of TBK1/IKKε mediated RIPK1 phosphorylation sensitizes tumors to immune cell killingAnastasia Piskopou, David W Vredevoogd, Xiangjun Kong, et al.
Cancer Cell|August 2, 2002
E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrestBenjamin D Rowland, Serguei G Denissov, Sirith Douma, et al.
The EMBO Journal|January 30, 2023
TSC2 regulates tumor susceptibility to TRAIL-mediated T-cell killing by orchestrating mTOR signalingChun-Pu Lin, Joleen J H Traets, David W Vredevoogd, et al.
Oncotarget|July 5, 2016
Integrated in vivo genetic and pharmacologic screening identifies co-inhibition of EGRF and ROCK as a potential treatment regimen for triple-negative breast cancerSedef Iskit, Cor Lieftink, Pasi Halonen, et al.
Nature Cell Biology|January 29, 2002
A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescenceDaniel S Peeper, Avi Shvarts, Thijn Brummelkamp, et al.
Pageof 12